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A Multicenter Review of Carotid Body Tumour Management
Sajid M.S., Hamilton G., Baker D.M., on behalf of Joint Vascular Research
Group . Eur J Vasc Endovasc Surg 2007;34:127-30.
Objective Carotid body tumour (CBT) is a rare but the most common
form of head and neck paraganglioma (PGL). We present the biggest ever
series on CBT in UK/EU discussing diagnostic challenges, surgical treat-
ment and complications of surgical intervention.
Method A detailed proforma was designed and sent to all members of
Joint Vascular Reasearch Group (JVRG). Data of 95 patients was collected.
Generic terms including carotid body tumour/s, or paraganglioma/s were
used to search a variety of electronic database in order to get latest informa-
tions available in literature.
Results A total of 95 patients were recorded in our data from 1979 to
2005. Mean age of presentation was 55 years. Incidence was higher in
females. CBT was more common on right side (58%). 18% tumours were
bilateral. Neck lump (98%) and pressure symptoms including cranial nerve
deficits and pain were main presenting complaints. About 18% of tumours
were familial. Only 4.2% were malignant. Duplex scan is the best investiga-
tion for diagnosis, though MRI, DSA and CT scan are important for
preoperative assessment. Surgery is the treatment of choice. Stroke and
cranial nerve injury constitute postoperative morbidity (35%) and mortality
(1%). Incidence of postoperative cranial nerve deficit was about 19%. Com-
bined ipsilateral and contralateral recurrence rate was 4.2%.
Conclusion CBT is a rare condition which needs surgical excision by
experienced vascular surgeon. Surgical resection is associated with significant
morbidity of 35% and mortality of 1%. Mostly CBT is benign but malignant
forms are not uncommon.
Influence of Antiplatelet Therapy on Cerebral Micro-Emboli after
Carotid Endarterectomy using Postoperative Transcranial Doppler
Monitoring
de Borst G.J., Hilgevoord A.A.J., de Vries J.P.P.M., van der Mee M., Moll
F.L., van de Pavoordt H.D.W.M., Ackerstaff R.G.A.. Eur J Vasc Endovasc
Surg 2007;34:135-42.
Aim To study the effect of different antiplatelet regimens (APT) on the
rate of postoperative TCD registered micro-embolic signals (MES) follow-
ing carotid endarterectomy (CEA).
Design Prospective, randomised, double-blinded, pilot study.
Methods The study group of 102 CEA patients (76 men, mean age
66.8 years) was randomised to routine Asasantin (Dipyridamole 200mg/
Aspirin 25mg) twice daily (group I; n39), Asasantin plus 75mg Clopi-
dogrel once daily (group II; n33), or Asasantin plus Rheomacrodex
(Dextran 40) 100g/L iv; 500ml (group III; n30). TCDmonitoring of the
ipsilateral middle cerebral artery for the occurrence of MES was performed
intra-operatively and during the second postoperative hour following CEA.
Primary endpoints were the rate of postoperative emboli and the occurrence
of cerebrovascular complications. Secondary endpoint was any adverse
bleeding.
Results There were no deaths or major strokes. We observed 2 intra-
operative TIA’s (group II and III) and 1 postoperative minor stroke (group
I). In comparison with placebo, Clopidogrel or Rheomacrodex in addition
to Asasantin produced no significant reduction in the number of postoper-
ative MES. There was no significant difference between the number of
postoperative MES and different antiplatelet regimens. The incidence of
bleeding complications was not significantly different between the 3 APT
groups.
Conclusion In the present study, we could not show a significant
influence of different antiplatelet regimens on TCD detected postoperative
embolization following CEA.
Endovascular Repair of Infrarenal Abdominal Aortic Aneurysms in
High-Risk-Surgical Patients
Jean-Baptiste E., Hassen-Khodja R., Bouillanne P.-J., Haudebourg P.,
Declemy S., Batt M.. Eur J Vasc Endovasc Surg 2007;34:145-51.
Purpose Following the publication of a prospective randomized trial
(EVAR2) that questioned the benefit of endovascular repair of abdominal
aortic aneurysms (AAA) for high-surgical-risk patients, we evaluated our
own initial and long-term results with endovascular AAA repair for this
patient population.
Material and methods Between January 2000 and December 2005,
115 patients with an AAA managed by an aortic endograft were entered in a
registry. Data concerning diagnosis, operative risk, treatment, and follow-up
were analyzed on an intention-to-treat basis for all patients considered to be
poor candidates for surgery. Patients with a ruptured AAA and those who
were good surgical candidates were excluded from analysis. The main goal
was evaluation of the operative mortality and the long-term survival of these
patients. Secondary goals were determination of the frequency of secondary
operations, the outcome of the aneurysm sac, and primary and secondary
patency rates after aortic endograft placement.
ResultsA total of 92 high-surgical-risk patients treated by an endograft
were entered in this study. Sixty-seven patients (73%) were classed ASA III
and 18 (20%) were ASA IV (20%). Mean aneurysm diameter was
58 mm9 mm. The technical success rate was 99%. Operative mortality was
4.3% (4 cases). Four patients required re-intervention during the mean
follow-up of 18 months. The survival rate at 3 yr was 85%. One type I
endoleak (1%) and 9 type II endoleaks (9.7%) occurred during the follow-up
period. Primary and secondary patency rates at 3 yr were respectively 96%
and 100%.
Conclusion Our initial and long-term results with endograft repair of
AAA in high-surgical-risk patients were satisfactory. These results appear to
justify endovascular repair for this patient population.
Factors Affecting Survival after Endovascular Aneurysm Repair: Re-
sults from a Population Based Audit
Boult M., Maddern G., Barnes M., Fitridge R.. Eur J Vasc Endovasc Surg
2007;34:156-62.
Objectives To determine the effect of pre-operative factors on mid-
term survival of patients enrolled in an Australian audit of endovascular
aneurysm repair (EVAR).
Design Prospective longitudinal national register (audit) of patients
undergoing EVAR.
Methods 961 individuals who had elective or semi-urgent EVAR of
abdominal aortic aneurysms were enrolled in the audit between November
1999 and May 2001. Data was contributed by 81 surgeons from 64
hospitals.
Kaplan-Meier survival analysis was used to determine survival rates and
factors significantly influencing survival. Parametric survival analysis with
log-exponential distribution was used to estimate expected 3 and 5 year
survival for different ages, ASA, creatinine and aneurysm sizes.
Results Overall survival was 93% at 1 year, 80% at 3 years and 67% at
five years. Survival rates were found to be statistically associated with ASA,
age, aneurysm size and creatinine levels. ASA has the largest effect. Five year
survival rates for aneurysms 65 mm and 55 mm were 54% and 76%
respectively. Pre-operative creatinine levels160 mol/L lowered the sur-
vival rate from 71% to 40%.
Conclusions Survival for EVAR patients is strongly correlated with a
number of pre-operative factors. This survival analysis provides a useful
decision-making tool for surgeons particularly for individuals with smaller
aneurysms.
Acute Limb Ischemia in Elderly Patients: Can Iloprost be Useful as an
Adjuvant to Surgery? Results from the ILAILL Study
de Donato G., Gussoni G., de Donato G., Cao P., Setacci C., Pratesi C.,
Mazzone A., Ferrari M., Veglia F., Bonizzoni E., Settembrini P., Ebner H.,
Martino A., Palombo D., on behalf of the ILAILL Study GroupaaThe
Members of the ILAILL Study Group are given in Appendix.. Eur J Vasc
Endovasc Surg 2007;34:194-98.
ObjectivesTo evaluate the effects of iloprost, in addition to surgery, on
the outcome of acute lower limb ischemia (ALLI).
Design Post-hoc analysis of a randomized, double-blind, placebo-
controlled study.
Methods In the context of the ILAILL (ILoprost in Acute Ischemia of
Lower Limbs) study, 192 elderly patients (70 years old) undergoing
surgery for ALLI were assigned to receive perioperative iloprost (intra-
arterial, intra-operative bolus of 3000 ng, plus intravenous infusion of
0.5–2.0 ng/kg/min for six hours/day for 4–7 days following surgery), or
placebo (iloprost: n100; placebo: n92). Patients were followed-up for
three-months following surgical revascularization.
397
Results The combined incidence of death and amputation (primary
study end-point) was significantly reduced in patients treated with iloprost
(16.0% vs 27.2% in the placebo group; hazard ratio 1.99, 95% confidence
interval 1.05–3.75, p0.03). A statistically significant lower mortality
(6.0%) was reported in patients receiving iloprost, compared to controls
(15.2%) (hazard ratio 2.93, 1.11–7.71, p0.03). The overall incidence of
death and major cardiovascular events was lower in patients receiving
iloprost compared to those assigned placebo (24.0% and 35.9%, respec-
tively), at the limits of statistical significance (relative risk 1.64, 0.97–2.79,
p0.06).
Conclusions These results confirm the poor outcome in elderly pa-
tients with ALLI. Based on a subgroup analysis iloprost, as an adjuvant to
surgery, appears to reduce the combined end-point of death and amputa-
tion.
The Australian Vascular Quality of Life Index (AUSVIQUOL): An
Improved Clinical Quality of Life Tool for Peripheral Vascular Disease
Smith M.J., Borchard K.L.A., Hinton E., Scott A.R.. Eur J Vasc Endovasc
Surg 2007;34:199-205.
Objectives To validate the Australian Vascular Quality of Life Index
(AUSVIQUOL) as a quality of life (QOL) tool appropriate for peripheral
vascular disease patients in the clinical setting.
Design Cross-sectional study.
Materials The study group consisted of 71 patients with vascular
claudication of varying severity attending a tertiary hospital outpatient
department.
Methods The results of the AUSVIQUOL and Medical Outcomes
Short Form Health Survey (SF-36) were compared through factor and
regression analyses. A group of 12 patients was then reassessed to compare
the reliability and internal consistency of the two indices.
Results The AUSVIQUOL took less time to complete than the SF-36
(3.27 v 10.79 min; p0.0001) and fewer patients found the questions
confusing (2% v 26%). The AUSVIQUOL was easier to administer and had
a higher level of patient acceptance than the SF-36. The regression analysis
showed that for each of the domains in the AUSVIQUOL there was a
significant correlation with measures in the SF-36 (adjusted R-squared
0.420, 0.480 and 0.331). The AUSVIQUOL demonstrated a good level of
internal consistency when compared to the SF-36 (Cronbach’s alpha 0.8702
vs 0.6307).
Conclusion In comparison with the SF-36, the AUSVIQUOL is an
improved tool for the QOL assessment of patients with peripheral vascular
disease in the clinical setting.
Prognostic Significance of Declining Ankle-brachial Index Values in
Patients with Suspected or Known Peripheral Arterial Disease
Feringa H.H.H., Karagiannis S.E., Schouten O., Vidakovic R., van Waning
V.H., Boersma E., Welten G., Bax J.J., Poldermans D.. Eur J Vasc Endovasc
Surg 2007;34:206-13.
Background Peripheral arterial disease (PAD) is a risk factor for
cardiovascular events. This study assessed the prognostic significance of
repeated ankle-brachial index (ABI) measurements at rest and after exercise
in patients with PAD receiving conservative treatment.
Methods In a cohort study of 606 patients (mean age 6212 years,
68% male), ABI at rest and after exercise was measured at baseline and after
1 year. Patients with reductions in ABI were divided into three equally-sized
groups (minor, intermediate and major reductions) and were compared to
patients without reductions. During a mean follow-up of 53 years, all-
cause mortality, cardiac events, stroke and progression to kidney failure were
noted.
Results Death was recorded in 83 patients (14%) of which 49% were
due to cardiac causes. Non-fatal myocardial infarction occurred in 38
patients (6%), stroke in 46 (8%) and progression to kidney failure in 35 (6%).
By multivariate analysis, patients with major declines in resting (20%) and
post-exercise (30%) ABI were at increased risk of all-cause mortality (HR:
3.3, 95% CI: 1.5–7.2, HR: 3.0, 95% CI: 1.4–6.4, respectively), cardiac
events (HR: 3.1, 95% CI: 1.3–7.2, HR: 2.4, 95% CI: 1.1–5.6, respectively),
stroke (HR: 4.2, 95% CI: 1.6–10.4, HR: 3.9, 95% CI: 1.4–10.2, respec-
tively) and kidney failure (HR: 2.7, 95% CI: 1.1–7.5, HR: 6.9, 95% CI:
1.5–31.5, respectively), compared to patients with no declines in ABI.
ConclusionsThis study shows that major 1-year declines in resting and
post-exercise ABI are associated with all-cause mortality, cardiac events,
stroke and kidney failure in patients with PAD.
Venous Reflux and Venous Distensibility in Varicose and Healthy
Veins
Jeanneret C., Jäger K.A., Zaugg C.E., Hoffmann U.. Eur J Vasc Endovasc
Surg 2007;34:236-42.
Objectives The aim of this study was to analyse venous diameter
changes and venous reflux parameters, assessed during a standardised Val-
salva manoeuvre in healthy subjects and in patients with varicose veins.
Methods Measurements were carried out in 444 vein segments, (96
legs of 48 healthy volunteers, 52 legs of 35 patients with varicose veins). The
common femoral vein (CVF), the femoral vein (FV) and the great saphenous
vein (GSV) were investigated. The parameters of reflux and the relative
venous diameter change (VD diff %) were measured simultaneously during a
standardised Valsalva manoeuvre.
Results Venous diameter changes during Valsalva manoeuvre (VD
diff) were significantly greater in the GSV and in the deep veins of varicose
patients compared to healthy subjects. The median (Interquartile range) of
VD max in the CFV was: 13.1 (3.5) mm and 11.2 (3.4) mm (p0.0002,
Mann-Whitney - U test), in the FV 7.8 (2.7) mm and 6.9 (2.0) mm
(p0.01, Mann-Whitney), in the GSV: 7.3 (3.7) mm and 4.2 (1.1) mm
(p0.0001, Mann-Whitney) for the varicose and healthy veins respectively.
Good correlation was seen for the retrograde peak reflux velocity (PRV) and
VD diff % in varicose veins (r0.71 (0.57 – 0.81) p0.0001, Mann-
Whitney).
Conclusion Relative venous diameter - changes during a standardised
Valsalvamanoeuvre are significantly larger in the deep and superficial veins of
varicose vein patients compared with healthy veins, the increased distensi-
bility correlates with venous reflux parameters in varicose vein patients.
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